Last 7 days
-3.1%
Last 30 days
-5.6%
Last 90 days
-24.7%
Trailing 12 Months
-51.2%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
SYK | 104.1B | 18.4B | 2.26% | 8.00% | 44.16 | 5.64 | 7.84% | 18.25% |
ISRG | 84.2B | 6.2B | -4.47% | -13.27% | 63.66 | 13.53 | 8.97% | -22.43% |
BSX | 69.1B | 12.7B | 0.59% | 12.45% | 99.06 | 5.45 | 6.68% | -32.95% |
BDX | 67.4B | 19.0B | -5.16% | -6.78% | 41.86 | 3.55 | -0.43% | -8.78% |
EW | 49.8B | 5.4B | 2.41% | -25.12% | 32.74 | 9.26 | 2.86% | 1.25% |
MID-CAP | ||||||||
SWAV | 7.2T | 489.7M | 9.34% | 31.15% | 82.2K | 16.8K | 106.51% | 2464.23% |
PEN | 10.2B | 847.1M | -3.64% | 34.52% | -5.1K | 12.05 | 13.32% | -137.89% |
GMED | 5.2B | 1.0B | -11.64% | -20.31% | 30.19 | 5.09 | 6.76% | 24.45% |
IRTC | 3.5B | 410.9M | 4.51% | -3.13% | -29.82 | 8.43 | 27.29% | -14.60% |
TNDM | 2.7B | 801.2M | 1.13% | -58.87% | -28.25 | 3.34 | 14.00% | -707.69% |
SMALL-CAP | ||||||||
SILK | 1.7B | 138.6M | -15.68% | 29.18% | -30.43 | 12.07 | 36.62% | -10.44% |
ATEC | 1.6B | 350.9M | 10.38% | 49.06% | -10.84 | 4.7 | 44.26% | -5.42% |
AVNS | 1.3B | 820.0M | -8.35% | -12.22% | 25.89 | 1.59 | 10.13% | 701.59% |
CSII | 828.4M | 239.8M | 0.30% | 1.49% | -21.88 | 3.45 | -4.74% | -31.15% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 2.5% | 15,113 | 14,740 | 14,193 | 13,545 | 12,784 |
Gross Profit | 1.1% | 5,397 | 5,340 | 5,528 | 5,308 | 5,105 |
S&GA Expenses | 0.7% | 3,887 | 3,860 | 3,593 | 3,292 | 2,867 |
R&D Expenses | 2.9% | 605 | 588 | 565 | 556 | 534 |
EBITDA | -1.0% | -1,345 | -1,332 | 2,011 | 2,030 | - |
EBITDA Margin | 1.5% | -0.09* | -0.09* | 0.14* | 0.15* | - |
Earnings Before Taxes | -2.6% | -2,353 | -2,294 | 1,123 | 1,220 | 1,477 |
EBT Margin | 0.0% | -0.16* | -0.16* | 0.08* | 0.09* | - |
Interest Expenses | -12.2% | -395 | -352 | -298 | -243 | -192 |
Net Income | -2.4% | -2,433 | -2,376 | 1,011 | 1,057 | 1,284 |
Net Income Margin | 0.1% | -0.16* | -0.16* | 0.07* | 0.08* | - |
Free Cahsflow | -17.3% | 1,211 | 1,465 | 1,850 | 2,053 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | 1.2% | 28,287 | 27,965 | 31,831 | 32,716 | 33,521 |
Current Assets | 2.6% | 8,011 | 7,810 | 7,882 | 8,173 | 8,872 |
Cash Equivalents | 7.3% | 1,718 | 1,601 | 1,852 | 2,294 | 2,951 |
Inventory | 1.6% | 2,718 | 2,675 | 2,663 | 2,548 | 2,453 |
Net PPE | -3.6% | 4,799 | 4,976 | 5,114 | 5,178 | - |
Goodwill | 3.1% | 6,843 | 6,639 | 9,644 | 9,816 | 9,836 |
Liabilities | 0.0% | 22,392 | 22,386 | 22,928 | 23,597 | 24,400 |
Current Liabilities | 28.0% | 4,745 | 3,708 | 3,916 | 3,890 | 4,236 |
. Short Term Borrowings | 8.7% | 299 | 275 | 200 | 200 | 301 |
Long Term Debt | -5.8% | 16,153 | 17,149 | - | - | - |
Shareholder's Equity | 5.4% | 5,833 | 5,535 | 8,903 | 9,119 | 9,077 |
Retained Earnings | 0.2% | 14,050 | 14,015 | 17,099 | 16,994 | 17,065 |
Additional Paid-In Capital | 0.4% | 6,322 | 6,297 | 6,253 | 6,207 | 6,197 |
Accumulated Depreciation | -3.7% | 6,285 | 6,528 | 6,643 | 6,550 | - |
Shares Outstanding | 0% | 504 | 504 | 503 | - | - |
Minority Interest | 40.9% | 62.00 | 44.00 | 44.00 | 44.00 | 44.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | -17.3% | 1,211 | 1,465 | 1,850 | 2,053 | 2,222 |
Share Based Compensation | -12.0% | 154 | 175 | 164 | 156 | 146 |
Cashflow From Investing | 91.5% | -931 | -10,942 | -10,965 | -10,966 | -11,200 |
Cashflow From Financing | -118.1% | -1,438 | 7,957 | 7,935 | 8,055 | 8,245 |
Dividend Payments | 1.1% | 573 | 567 | 562 | 545 | 530 |
Buy Backs | 0% | 32.00 | 32.00 | 35.00 | 347 | 600 |
32.7%
13.1%
7.7%
Y-axis is the maximum loss one would have experienced if Baxter International was unfortunately bought at previous high price.
1.6%
0.4%
-9.9%
-21.4%
FIve years rolling returns for Baxter International.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-15 | B. Riley Wealth Advisors, Inc. | reduced | -17.2 | -90,575 | 334,425 | 0.01% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | added | 2.77 | -2,022,390 | 71,739,600 | 0.08% |
2023-03-06 | BIRMINGHAM CAPITAL MANAGEMENT CO INC/AL | added | 2.16 | -28,682 | 844,318 | 0.32% |
2023-03-06 | Rockefeller Capital Management L.P. | reduced | -0.93 | -106,000 | 1,602,000 | 0.01% |
2023-03-03 | TIAA, FSB | reduced | -4.23 | -101,806 | 990,194 | -% |
2023-03-02 | LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA | new | - | 104,743 | 104,743 | -% |
2023-03-02 | OLIVER LAGORE VANVALIN INVESTMENT GROUP | unchanged | - | -1,464 | 25,536 | 0.01% |
2023-03-01 | WHITENER CAPITAL MANAGEMENT, INC. | added | 0.59 | -43,406 | 874,594 | 0.38% |
2023-03-01 | PANORAMIC INVESTMENT ADVISORS, LLC | new | - | 328,094 | 328,094 | 0.34% |
2023-02-28 | Voya Investment Management LLC | reduced | -5.15 | -1,801,890 | 15,793,100 | 0.02% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 09, 2023 | vanguard group inc | 9.86% | 49,705,350 | SC 13G/A | |
Feb 08, 2023 | morgan stanley | 5.5% | 27,835,167 | SC 13G/A | |
Feb 06, 2023 | wellington management group llp | 7.16% | 36,104,233 | SC 13G/A | |
Jan 06, 2023 | blackrock inc. | 10.0% | 50,522,292 | SC 13G/A | |
Mar 10, 2022 | wellington management group llp | 11.33% | 56,894,500 | SC 13G/A | |
Feb 09, 2022 | morgan stanley | 5.7% | 28,501,661 | SC 13G | |
Feb 09, 2022 | vanguard group inc | 7.79% | 38,980,284 | SC 13G/A | |
Feb 04, 2022 | wellington management group llp | 9.91% | 49,623,775 | SC 13G/A | |
Feb 01, 2022 | blackrock inc. | 8.0% | 40,110,136 | SC 13G/A | |
Apr 12, 2021 | wellington management group llp | 10.11% | 51,116,416 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | - - | - - | - - | - - | - - |
Current Inflation | 31.03 -19.13% | 36.70 -4.35% | 52.54 36.93% | 63.63 65.83% | 75.19 95.96% |
Very High Inflation | - - | - - | - - | - - | - - |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 13, 2023 | 8-K | Current Report | |
Mar 07, 2023 | 4 | Insider Trading | |
Mar 07, 2023 | 4 | Insider Trading | |
Mar 07, 2023 | 4 | Insider Trading | |
Mar 06, 2023 | 4 | Insider Trading | |
Mar 06, 2023 | 4 | Insider Trading | |
Mar 06, 2023 | 4 | Insider Trading | |
Mar 06, 2023 | 4 | Insider Trading | |
Mar 06, 2023 | 4 | Insider Trading | |
Mar 06, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-03 | Rasul Reaz | sold (taxes) | -5,911 | 39.94 | -148 | evp, group pres, healthcare |
2023-03-03 | Knight Heather | sold (taxes) | -8,786 | 39.94 | -220 | evp, group pres, medical |
2023-03-03 | Stevens Brian | sold (taxes) | -7,348 | 39.94 | -184 | svp, cao and controller |
2023-03-02 | Rasul Reaz | sold (taxes) | -16,481 | 39.62 | -416 | evp, group pres, healthcare |
2023-03-02 | ALMEIDA JOSE E | sold (taxes) | -183,916 | 39.62 | -4,642 | chairman, ceo and president |
2023-03-02 | SACCARO JAMES | sold (taxes) | -42,036 | 39.62 | -1,061 | evp, chief financial officer |
2023-03-02 | Mason Jeanne K | sold (taxes) | -18,225 | 39.62 | -460 | svp, human resources |
2023-03-02 | Franzi Cristiano | sold (taxes) | -5,784 | 39.62 | -146 | svp, president, emea |
2023-03-02 | Kunzler Jacqueline | sold (taxes) | -10,737 | 39.62 | -271 | svp, chief quality officer |
2023-03-02 | Borzi James W | sold (taxes) | -18,779 | 39.62 | -474 | svp, global supply chain |
Condensed Consolidated Statements of Income (Loss) (unaudited) - USD ($) shares in Millions, $ in Millions | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Income Statement [Abstract] | ||||
Net sales | $ 3,773 | $ 3,226 | $ 11,226 | $ 9,270 |
Cost of sales | 2,640 | 1,905 | 7,292 | 5,571 |
Gross margin | 1,133 | 1,321 | 3,934 | 3,699 |
Selling, general and administrative expenses | 947 | 680 | 2,975 | 1,982 |
Research and development expenses | 152 | 129 | 450 | 396 |
Goodwill impairments | 2,785 | 0 | 2,785 | 0 |
Other operating expense (income), net | 48 | (1) | 20 | (6) |
Operating income (loss) | (2,799) | 513 | (2,296) | 1,327 |
Interest expense, net | 104 | 50 | 278 | 118 |
Other (income) expense, net | 63 | 12 | 3 | 15 |
Income (loss) before income taxes | (2,966) | 451 | (2,577) | 1,194 |
Income tax expense (benefit) | (32) | (1) | 29 | 141 |
Net income (loss) | (2,934) | 452 | (2,606) | 1,053 |
Net income attributable to noncontrolling interests | 3 | 2 | 8 | 7 |
Net income (loss) attributable to Baxter stockholders | $ (2,937) | $ 450 | $ (2,614) | $ 1,046 |
Earnings (loss) per share | ||||
Basic (in dollars per share) | $ (5.83) | $ 0.90 | $ (5.20) | $ 2.08 |
Diluted (in dollars per share) | $ (5.83) | $ 0.89 | $ (5.20) | $ 2.06 |
Weighted-average number of shares outstanding | ||||
Basic (in shares) | 504 | 500 | 503 | 503 |
Diluted (in shares) | 504 | 506 | 503 | 509 |
Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Millions | Sep. 30, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 1,601 | $ 2,951 |
Accounts receivable, net of allowances of $120 in 2022 and $122 in 2021 | 2,555 | 2,629 |
Inventories | 2,675 | 2,453 |
Prepaid expenses and other current assets | 979 | 839 |
Total current assets | 7,810 | 8,872 |
Property, plant and equipment, net | 4,799 | 5,178 |
Goodwill | 6,639 | 9,836 |
Other intangible assets, net | 6,927 | 7,792 |
Operating lease right-of-use assets | 546 | 630 |
Other non-current assets | 1,244 | 1,213 |
Total assets | 27,965 | 33,521 |
Current liabilities: | ||
Short-term debt | 275 | 301 |
Current maturities of long-term debt and finance lease obligations | 4 | 210 |
Accounts payable | 1,234 | 1,246 |
Accrued expenses and other current liabilities | 2,195 | 2,479 |
Total current liabilities | 3,708 | 4,236 |
Long-term debt and finance lease obligations, less current portion | 16,153 | 17,149 |
Operating lease liabilities | 454 | 522 |
Other non-current liabilities | 2,071 | 2,493 |
Total liabilities | 22,386 | 24,400 |
Commitments and contingencies | ||
Equity: | ||
Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2022 and 2021 | 683 | 683 |
Common stock in treasury, at cost,179,451,293 shares in 2022 and 181,879,516 shares in 2021 | (11,406) | (11,488) |
Additional contributed capital | 6,297 | 6,197 |
Retained earnings | 14,015 | 17,065 |
Accumulated other comprehensive income (loss) | (4,054) | (3,380) |
Total Baxter stockholders’ equity | 5,535 | 9,077 |
Noncontrolling interests | 44 | 44 |
Total equity | 5,579 | 9,121 |
Total liabilities and equity | $ 27,965 | $ 33,521 |